SCHEMBL1767723

SCHEMBL1767723

CCC(C)(C)C(C)(C)c1cccc(O)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.41
ESR2 Q92731 2/20 0.41
ALDH1A1 P00352 2/20 0.41
CYP3A4 P08684 2/20 0.41
CA12 O43570 1/20 0.41
CA2 P00918 1/20 0.41
LMNA P02545 1/20 0.41
CA5A P35218 1/20 0.41
CA9 Q16790 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CA14 Q9ULX7 1/20 0.41
CA5B Q9Y2D0 1/20 0.41
KIF11 P52732 4/20 0.39
ACHE P22303 5/20 0.39
OPRM1 P35372 2/20 0.39
TSHR P16473 1/20 0.39
BLM P54132 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HSD17B1 P14061 1/20 0.38
HSD17B2 P37059 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31441290 1.00 ESR1 (0.41) ESR1ESR2ALDH1A1CYP3A4CA12
SCHEMBL13930904 0.80 ESR1 (0.44) ESR1ESR2ALDH1A1CYP3A4CA12
SCHEMBL825377 0.80 LMNA (0.44) ESR1ESR2ALDH1A1CYP3A4CA12
SCHEMBL31215161 0.80 LMNA (0.44) ESR1ESR2ALDH1A1CYP3A4CA12
SCHEMBL11783483 0.80 ALDH1A1 (0.44) ESR1ESR2ALDH1A1CYP3A4CA12
SCHEMBL393199 0.79 ESR1 (0.58) ESR1ESR2ALDH1A1CYP3A4CA12
SCHEMBL2399948 0.78 ESR1 (0.42) ESR1ESR2ALDH1A1CYP3A4CA12
SCHEMBL13815889 0.78 ESR1 (0.42) ESR1ESR2ALDH1A1CYP3A4CA12
SCHEMBL29210903 0.78 HSD17B10 (0.44) ESR1ESR2CYP3A4LMNAHSD17B10
Phenol SCHEMBL616489 0.77 ESR1 (0.53) ESR1ESR2ALDH1A1CYP3A4CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021063609-A1 BISMUTH OXYCHLORIDE-CONTAINING SUNSCREEN FOR PROTECTION FROM BLUE LIGHT BEIERSDORF AG (DE) 2021-04-08 WO claimed
EP-3651725-A1 SUNSCREEN WITH PROTECTION AGAINST TEXTILE SPOTTING DUE TO 2,4-BIS-{[4-(2-ETHYL-HEXYL-OXY)-2-HYDROXY]-PHENYL}-6-(4-METHOXYPHENYL)-1,3,5-TRIAZINE Beiersdorf AG (DE) 2020-05-20 EP claimed
EP-2516494-A1 METHOD OF CONVERTING A POLYMERIZABLE COMPOSITION INTO THERMOPLASTIC POLYURETHANE OF IMPROVED YELLOWNESS INDEX AND ARTICLE OBTAINED BY THIS METHOD Essilor International (Compagnie Générale D'Optique) (FR) 2012-10-31 EP claimed
WO-2011078840-A1 METHOD OF CONVERTING A POLYMERIZABLE COMPOSITION INTO THERMOPLASTIC POLYURETHANE OF IMPROVED YELLOWNESS INDEX AND ARTICLE OBTAINED BY THIS METHOD ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) 2011-06-30 WO claimed
CN-117858702-A Mexiletine sustained release composition for oral administration 鲁平亚特兰蒂斯控股公司 2024-04-09 CN disclosed
WO-2024005194-A1 POLYPHENOL COMPOUND, FILM-FORMING COMPOSITION FOR LITHOGRAPHY, UNDERLAYER FILM FOR LITHOGRAPHY, AND METHOD FOR FORMING PATTERN 三菱瓦斯化学株式会社 2024-01-04 WO disclosed
WO-2023178500-A1 THERAPEUTIC VESICLES AND METHODS OF PROCESSING THE SAME BEIJING THERAXYTE BIOSCIENCE CO. LTD. (CN) 2023-09-28 WO disclosed
WO-2023108588-A1 PROCESS FOR PRODUCING CABLE WITH INSULATION LAYER DOW GLOBAL TECHNOLOGIES LLC (US) 2023-06-22 WO disclosed
WO-2023108586-A1 OLEFIN/SILANE INTERPOLYMER COMPOSITIONS WITH EXCELLENT THERMAL OXIDATION RESISTANCE DOW GLOBAL TECHNOLOGIES LLC (US) 2023-06-22 WO disclosed
WO-2023080257-A1 METHOD FOR PRODUCING ISOCYANATE COMPOUNDS, METHOD FOR PRODUCING CARBAMATE COMPOUNDS, METHOD FOR RECOVERING AMINE COMPOUNDS, AND ISOCYANATE COMPOSITION 旭化成株式会社 2023-05-11 WO disclosed
CN-116018154-A Phage composition for treating pseudomonas infection 阿玛塔制药公司 2023-04-25 CN disclosed
CN-112055731-B High strength additive manufactured articles 高新特殊工程塑料全球技术有限公司 2023-04-25 CN disclosed
WO-1999023093-A1 2-(2'-HYDROXYPHENYL)BENZOTRIAZOLES USED AS U.V. STABILISERS GREAT LAKES CHEMICAL (EUROPE) GMBH (CH) 1999-05-14 WO disclosed
EP-0906112-A2 USE OF ALKYLARYL POLYETHER ALCOHOL POLYMERS FOR THE TREATMENT OF CHRONIC PULMONARY INFLAMMATION CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY doing business as Carolinas Medical Center (US) 1999-04-07 EP disclosed
EP-0817638-A2 METHOD OF MUCOCILIARY CLEARANCE IN CYSTIC FIBROSIS PATIENTS USING ALKYLARYL POLYETHER ALCOHOL POLYMERS DUKE UNIVERSITY (US) 1998-01-14 EP disclosed
WO-1997038699-A2 USE OF ALKYLARYL POLYETHER ALCOHOL POLYMERS FOR THE TREATMENT OF CHRONIC PULMONARY INFLAMMATION CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY DOING BUSINESS AS CAROLINAS MEDICAL CENTER (US) 1997-10-23 WO disclosed
WO-1997023449-A1 ANIONIC SURFACTANTS HAVING MULTIPLE HYDROPHOBIC AND HYDROPHILIC GROUPS RHONE-POULENC INC. (US) 1997-07-03 WO disclosed
WO-1996030028-A2 METHOD OF MUCOCILIARY CLEARANCE IN CYSTIC FIBROSIS PATIENTS USING ALKYLARYL POLYETHER ALCOHOL POLYMERS DUKE UNIVERSITY (US) 1996-10-03 WO disclosed
EP-0135510-A1 NEW MEDICAMENTS PERTAINING TO THE FAMILY OF HALOGENOBENZOPHENONE-OXIME DERIVATIVE. INST RECH CHIM BIOLOG (FR) 1985-04-03 EP disclosed
WO-1984002844-A1 NEW MEDICAMENTS PERTAINING TO THE FAMILY OF HALOGENOBENZOPHENONE-OXIME DERIVATIVE INST RECH CHIM BIOLOG (FR) 1984-08-02 WO disclosed